跳至主要内容
临床试验/NL-OMON55624
NL-OMON55624已完成3 期

Cardiac changes after stereotactic radiotherapy for early stage NSCLC cancer or lung metastasis - HALO - HALO

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, the patient must meet all
  • of the following criteria:
  • - Receive SBRT treatment for stage 1A-2B NSCLC or for a solitary lung
  • metastasis of a solid tumor
  • - Closest distance between edge of tumor and heart < 3 cm, measured on the
  • diagnostic CT scan using lung window setting (W*=*1600 and L*=**600)

排除标准

  • - a pacemaker/implantable cardioverter-defibrillator (ICD), as these cannot be
  • scanned in MRI
  • - a renal function below GFR <60 ml/min/1.7m2, because administration of MRI
  • contrast will then not be desirable

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Cardiac changes after stereotactic radiotherapy for... | 临床试验